Pinned Tweet
🏮Announcing the Lantern Summit in Shanghai🏮
In 2025, more new medicines launched first in China than anywhere else on Earth.
That has never happened before.
Drug development has two simultaneous accelerators:
• AI is collapsing design (weeks instead of years).
• China is collapsing development (physical iteration speed).
Here is why that matters, and what Western biotech is missing: 🧵
Dr. Guoxin Zhu joins us at The Lantern Summit.
SVP and Global Head of Research at Hengrui. Ex-VP of Molecule Discovery at Eli Lilly, where he oversaw 100+ small molecule clinical candidates.
Shanghai · 26–27 Oct 2026
thelanternsummit.com 🏮
Dr. Yue Wang joins us at The Lantern Summit.
VP at AstraZeneca China R&D and Head of Digital Health. Her teams have supported 15 innovative medicine approvals and 35 new indications in China.
Shanghai · 26–27 Oct 2026
thelanternsummit.com 🏮
Katherine Jones joins us at The Lantern Summit.
First operations hire at @merge, the ultrasound BCI company co-founded by Sam Altman. Led neurotech investing at Hummingbird. Now at @JoinEdgeCity.
Shanghai · 26–27 Oct 2026
thelanternsummit.com
Jeff Wang joins us at The Lantern Summit.
Founder of Global Pharma Navigator, a network of 30,000+ manufacturers across Chinese biopharma. A decade in API manufacturing before he built it.
Shanghai · 26–27 Oct 2026
thelanternsummit.com🏮
Phoenix Peng joins us at The Lantern Summit.
Founder & CEO of Gestala, China's first ultrasound brain-computer interface company: RMB 570M raised since January. Co-founded NeuroXess before that.
Shanghai · 26–27 Oct 2026
thelanternsummit.com
Dato’ William Woo joins us at The Lantern Summit.
Chairman and CEO of ChemPartner, the drug discovery CRO and CDMO. Co-founder of Perfect China. Thirty years building healthcare businesses in China.
Shanghai · 26–27 Oct 2026
thelanternsummit.com
Dr. Dan Zhang joins us at The Lantern Summit.
Founder of Fountain Medical Development, now ClinChoice, and co-chairman of cell-therapy CDMO Hillgene. Fudan professor, ICH expert, PUMC medical doctorate.
Shanghai · 26–27 Oct 2026
thelanternsummit.com 🏮
Roberta lipson joins us at The Lantern Summit.
Founder of United Family Healthcare. Co-founded Chindex in 1981 and opened China’s first foreign-invested hospital in 1997. Chair emeritus of AmCham China.
Shanghai · 26–27 Oct 2026
thelanternsummit.com 🏮
Ugur Sahin led the development of the first approved mRNA COVID-19 vaccine and helped establish mRNA as a new class of medicine.
He keynotes The Lantern Summit: “From Science to Survival: a personal perspective on turning ideas into impact for patients.”
Shanghai · 26–27 Oct 2026
thelanternsummit.com 🏮
LanternSummit retweeted
Bio is having its China moment.
Just booked flights to join & add a bit of California Peptide Club flavor.
DM me if you're coming or are interested!
🏮Announcing the Lantern Summit in Shanghai🏮
In 2025, more new medicines launched first in China than anywhere else on Earth.
That has never happened before.
Drug development has two simultaneous accelerators:
• AI is collapsing design (weeks instead of years).
• China is collapsing development (physical iteration speed).
Here is why that matters, and what Western biotech is missing: 🧵
Michael Yin joins us at The Lantern Summit.
Chairman of Suzhou BioBAY, the park that helped make Suzhou Industrial Park China's top-ranked biopharma cluster. He also hosts our optional Day 3 visit.
Shanghai · 26–27 Oct 2026
thelanternsummit.com 🏮
Wenliang Lei joins us at The Lantern Summit.
PI at Jinan University's GHM Institute of CNS Regeneration. His lab builds primate models of Alzheimer's and tests AAV gene therapy in them.
Shanghai · 26–27 Oct 2026
thelanternsummit.com🏮
Jeff He joins us at The Lantern Summit.
Co-founder and CEO of TandemAI, pairing AI and physics-based models with wet labs in the US and China. Co-founded HiFiBiO and Harbour BioMed before that.
Shanghai · 26–27 Oct 2026
thelanternsummit.com🏮
Alan Jiang joins us at The Lantern Summit.
Chief Strategy Officer at @XtalPi (2228.HK), where AI, quantum physics and robotic labs meet drug R&D. Twenty years at Genzyme and Sanofi before that.
Shanghai · 26–27 Oct 2026
thelanternsummit.com 🏮
Jielun Zhu joins us at The Lantern Summit.
Co-founder, CFO & CBO of Excalipoint, whose $68.7M seed is among the largest ever for a Chinese biotech. Led I-Mab's Nasdaq IPO as CFO before that.
Shanghai · 26–27 Oct 2026
thelanternsummit.com🏮
Kerry Blanchard joins us at The Lantern Summit.
CEO of Perpetual Medicines and President of R&D at TandemAI. Four decades of drug hunting, the last 16 in China: Lilly China, Innovent, Everest Medicines.
Shanghai · 26–27 Oct 2026
thelanternsummit.com🏮
Carol Magalhaes joins us at The Lantern Summit.
Co-founder of Autonomy Bio, an age1-incubated company working on healthy lifespan. George Church's lab before that; left a Stanford PhD to build it.
Shanghai · 26–27 Oct 2026
thelanternsummit.com 🏮
Vince Deng joins us at The Lantern Summit.
CFO of OnTargetBio and Venture Partner at Med-Fine Capital, a seed investor in Excalipoint. Glycoscientist by training; published in Cell and PNAS.
Shanghai · 26–27 Oct 2026
thelanternsummit.com 🏮
Dan Wee joins us at The Lantern Summit.
Chief eXecution Officer at @enveda since before the seed round. Enveda closed a $311M Series E in September at a $2B valuation, three medicines in the clinic.
Shanghai · 26–27 Oct 2026
thelanternsummit.com 🏮
We're selecting 10 early-stage techbio companies from China and the West to pitch at The Lantern Summit.
Meet investors and operators from Greater China, Europe and the US.
Shanghai · October 27.
Apply by October 15th:
thelanternsummit.com/pitch-t…
We want to help founders find investors and partners beyond their home ecosystem.
There is no fee to apply or pitch.
Submit an English-language deck by October 15th.
Apply, or pass this on to a founder:
thelanternsummit.com/pitch-t…





















